GSA Capital Partners’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-41,068
Closed -$53K 1866
2018
Q4
$53K Buy
41,068
+20,300
+98% +$35.3K 0.01% 1261
2018
Q3
$72K Buy
20,768
+6,200
+43% +$23.3K ﹤0.01% 1579
2018
Q2
$66K Buy
+14,568
New +$58K ﹤0.01% 1613

Other funds holding IMDZ

GSA Capital Partners's IMDZ Position: Q1 2019 in Review

GSA Capital Partners sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 41,068 shares — an estimated $53K sold.

GSA Capital Partners first reported a position in IMDZ in Q2 2018 and held it in 3 quarters. The position peaked at $72K in Q3 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

  • GSA Capital Partners reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
  • GSA Capital Partners sold 41,068 Immune Design Corp. shares in Q1 2019, an estimated $53K.
  • GSA Capital Partners first reported a position in Immune Design Corp. in Q2 2018 and held it in 3 quarters.
  • GSA Capital Partners's Immune Design Corp. position peaked at $72K in Q3 2018.
  • 68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.